Spiolto Respimat 2.5 mcg / 2.5 mcg
Spiolto Respimat 2.5 mcg / 2.5 mcg is a medicine authorised by Swissmedic under authorisation number 67352. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 April 2019 and the authorisation is valid without a time limit. ATC code R03AL06 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 67352 |
|---|---|
| Name | Spiolto Respimat 2.5 mcg / 2.5 mcg |
| Full name | Spiolto Respimat 2.5 mcg / 2.5 mcg, Lösung zur Inhalation (wiederverwendbar) |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03AL06 |
| First authorisation | 11 April 2019 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Spiolto Respimat 2.5 mcg / 2.5 mcg, Lösung zur Inhalation (wiederverwendbar) | B | 11 April 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Stück | R03AL06 | 03.04.3. | B |
| 2 | 3 | Stück | R03AL06 | 03.04.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Spiolto Respimat 2.5 mcg / 2.5 mcg authorised in Switzerland?
Yes. Spiolto Respimat 2.5 mcg / 2.5 mcg is authorised by Swissmedic under authorisation number 67352, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Spiolto Respimat 2.5 mcg / 2.5 mcg have?
Spiolto Respimat 2.5 mcg / 2.5 mcg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Spiolto Respimat 2.5 mcg / 2.5 mcg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.